Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Latrogenic platelet dysfunction: an emerging peril.

S A Wolfe, E C Lian

    Plastic and Reconstructive Surgery
    |May 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Molecular, Morphological, and Functional Characterization of Corticotropin-Releasing Factor Receptor 1-Expressing Neurons in the Central Nucleus of the Amygdala.

    eNeuro·2019
    Same author

    Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish.

    Developmental cell·2014
    Same author

    Correction of the "Simian" forehead deformity.

    Aesthetic plastic surgery·2013
    Same author

    A rapid enzyme-linked assay for ADAMTS-13.

    Journal of thrombosis and haemostasis : JTH·2006
    Same author

    Autogenous bone grafts and bone substitutes--tools and techniques: I. A 20,000-case experience in maxillofacial and craniofacial surgery.

    Plastic and reconstructive surgery·2005
    Same author

    Transcriptional control of the testis-specific histone H1t gene.

    Gene·2003
    Same journal

    "Inferior Repositioning of the High-Riding Nipple Using a Parenchymal-Based Flap".

    Plastic and reconstructive surgery·2026
    Same journal

    A Four-Step Strategy for the Treatment of Facial Rhytids: A Focus on Upper Facial Wrinkles.

    Plastic and reconstructive surgery·2026
    Same journal

    Evaluating Long-Term Retention of Fresh-Frozen Costal Cartilage Allograft in An Animal Model.

    Plastic and reconstructive surgery·2026
    Same journal

    Manual extrusion of fat granules for primary thinning of a bulky flap.

    Plastic and reconstructive surgery·2026
    Same journal

    "Impact of regional surgeon competition on use and costs of carpal tunnel releases".

    Plastic and reconstructive surgery·2026
    Same journal

    Prevention of Tendon Adhesion and Preservation of Healing Strength Using a Hydrophobically Modified Alaska Pollock Gelatin Sheet.

    Plastic and reconstructive surgery·2026
    See all related articles

    Abnormal bleeding after facelifts can occur due to a combination of clofibrate and xylocaine, which significantly impair platelet function. This drug interaction, affecting normal individuals, highlights a potential risk for patients undergoing cosmetic surgery.

    Area of Science:

    • Pharmacology
    • Hematology
    • Cosmetic Surgery

    Background:

    • Abnormal bleeding is a potential complication following surgical procedures, including facelifts.
    • Platelet dysfunction can lead to increased hemorrhage.
    • Certain medications may interfere with normal hemostasis.

    Purpose of the Study:

    • To investigate the cause of abnormal bleeding observed after a facelift procedure.
    • To determine the role of clofibrate and xylocaine in post-facelift bleeding.
    • To assess the mechanism of drug-induced platelet dysfunction.

    Main Methods:

    • Case study of a patient experiencing abnormal bleeding post-facelift.
    • In vitro experiments using platelets from normal individuals.
    • Synergistic effect analysis of clofibrate and xylocaine on platelet function.

    Related Experiment Videos

    Main Results:

    • Abnormal bleeding was attributed to the synergistic effect of clofibrate and xylocaine.
    • The combination profoundly interfered with platelet function.
    • This effect was reproducible in vitro, indicating it is not an idiosyncratic reaction.

    Conclusions:

    • The combination of clofibrate and xylocaine poses a risk for abnormal bleeding after facelifts due to significant platelet dysfunction.
    • Physicians should be aware of this drug interaction in patients seeking cosmetic surgery.
    • Caution is advised regarding the use of clofibrate in individuals undergoing or considering facelift procedures.